Medicure (MCUJF) EBIT Margin (2009 - 2026)
Medicure (MCUJF) recorded quarterly EBIT Margin of 20.06% in Q1 2026, up 2125.38% quarter-over-quarter from 0.9% in Q4 2025, and up 3200.0% on a YoY basis from 0.61% in Q1 2025.
Medicure (MCUJF) EBIT Margin (2009 - 2026) Analysis & Trends
Medicure's EBIT Margin history runs 18 years deep, the most recent figure standing at 20.06% for Q1 2026.
- In Q1 2026, EBIT Margin rose 3200.0% year-over-year to 20.06%; the TTM figure through Mar 2026 stood at 6.0% (up 2190.0% YoY), while the FY2025 annual figure was 23.87%, down 1138.0% from the prior year.
- EBIT Margin was 20.06% for Q1 2026 at Medicure, up from 0.9% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 92.89% in Q1 2023 to a low of 22.45% in Q3 2024.
- Historically, EBIT Margin has averaged 11.8% across 5 years, with a median of 1.82% in 2023.
- The sharpest annual moves came in 2023 and 2024: EBIT Margin surged 5147 bps in 2023, then sank 9223 bps in 2024.
- A 5-year view of EBIT Margin shows it stood at 85.73% in 2022, then sank by 93 bps to 6.29% in 2023, then sank by 235 bps to 8.48% in 2024, then jumped by 111 bps to 0.9% in 2025, then surged by 2125 bps to 20.06% in 2026.
- The last three EBIT Margin figures came in at 20.06% (Q1 2026), 0.9% (Q4 2025), and 10.9% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Medicure | - | - | 2.57 Mn | 20.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.06% |
| Dec 31, 2025 | 0.90% |
| Sep 30, 2025 | 10.90% |
| Jun 30, 2025 | -10.48% |
| Mar 31, 2025 | -11.94% |
| Dec 31, 2024 | -8.48% |
| Sep 30, 2024 | -22.45% |
| Jun 30, 2024 | -21.65% |
| Mar 31, 2024 | 0.67% |
| Dec 31, 2023 | 6.29% |
| Sep 30, 2023 | 1.82% |
| Jun 30, 2023 | 5.46% |
| Mar 31, 2023 | 92.89% |
| Dec 31, 2022 | 85.73% |
| Sep 30, 2022 | 16.11% |
| Jun 30, 2022 | -6.66% |
| Mar 31, 2022 | 41.43% |
| Sep 30, 2021 | -4.85% |
| Jun 30, 2021 | -15.18% |
| Mar 31, 2021 | 37.34% |